There are approximately 18 million cancer cases have been observed per year worldwide according to Global cancer therapy (GLOBOCAN). Chemotherapy, radiotherapy and surgery have been mostly used for cancer therapy. The maximum tolerated dose is currently being used to cure patients. The incorporated advancement of modern nanoparticle-based techniques will be important to find one of the main issues in both radiotherapy and chemotherapy: normal tissue toxicity. The Gold Nanoparticle (GNP) based systems are very helpful to further improve chemotherapy by controlled releases of chemotherapeutics, but local radiotherapy dose can be improved through targeting the GNPs to the tumor. Over 20 nanotechnology-based therapeutic products have been authorized for clinical use in the past two decades. The main purpose of this review article is to understand how we can accelerate the clinical use of GNP-based therapeutic system to reduce normal tissue toxicity while increasing the worth of the treatment. Nanomedicines will change future cancer treatment methods in a better way that has minimum side effects.
Keywords:
Published on: Jan 19, 2021 Pages: 19-25
Full Text PDF
Full Text HTML
DOI: 10.17352/2455-3492.000040
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."